Fund Holdings — Palo Alto Investors LP

Total Portfolio Value:
$1.11B
Total Bought:
$157.28M
Total Sold:
$111.13M
Net Transaction:
+$46.15M
Notable People:
Palo Alto Investors Gp Llc
Securities
▲▼
SharesValue
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
Insmed Incorporated(INSM)5,889,4915,511,721-377,770$148.71M$170.81M15.39%+$22.10M
Amicus Therapeutics Inc
COM
10,524,02210,373,715-150,307$127.97M$147.20M13.26%+$19.23M
BioMarin Pharmaceutical Inc.(BMRN)1,831,0351,500,749-330,286$162.01M$144.70M13.04%-$17.31M
Biogen Inc.(BIIB)381,282380,417-865$97.99M$98.44M8.87%+$447.2K
United Therapeutics Corporation(UTHR)575,907395,784-180,123$130.08M$87.03M7.84%-$43.05M
Acadia Pharmaceuticals Inc2,405,7932,409,556+3,763$50.14M$75.44M6.80%+$25.31M
Prothena Corp PlcSHS
SHS
1,657,4581,660,057+2,599$79.97M$60.33M5.44%-$19.65M
Revance Therapeutics Inc5,228,6095,237,284+8,675$59.97M$46.04M4.15%-$13.94M
STAAR Surgical Company(STAA)1,374,8221,376,950+2,128$55.24M$42.97M3.87%-$12.27M
Alnylam Pharmaceuticals, Inc.(ALNY)0154,437+154,437$0$29.56M2.66%+$29.56M
eHealth, Inc.(EHTH)2,739,3792,739,3790$20.27M$23.89M2.15%+$3.62M
Sage Therapeutics Inc1,005,776991,525-14,251$20.70M$21.49M1.94%+$787.5K
Sarepta Therapeutics, Inc.(SRPT)94,030200,905+106,875$11.40M$19.37M1.75%+$7.97M
Iovance Biotherapeutics, Inc.(IOVA)02,106,792+2,106,792$0$17.13M1.54%+$17.13M
Alkermes plcSHS(ALKS)603,400603,4000$16.90M$16.74M1.51%-$162.9K
Nevro Corp386,832750,371+363,539$7.43M$16.15M1.45%+$8.71M
Align Technology Inc55,70555,7050$17.01M$15.26M1.38%-$1.74M
Anaptysbio Inc431,224686,882+255,658$7.74M$14.71M1.33%+$6.97M
Syndax Pharmaceuticals, Inc.(SNDX)472,600472,6000$6.86M$10.21M0.92%+$3.35M
Cytokinetics, Incorporated(CYTK)111,717111,7170$3.29M$9.33M0.84%+$6.04M
NovoCure Limited(NVCR)660,275561,908-98,367$10.66M$8.39M0.76%-$2.27M
Verve Therapeutics Inc0575,817+575,817$0$8.03M0.72%+$8.03M
Gossamer Bio, Inc.(GOSS)6,530,2885,958,888-571,400$5.44M$6.53M0.59%+$1.09M
Bluebird Bio Inc03,333,333+3,333,333$0$4.60M0.41%+$4.60M
Karyopharm Therapeutics Inc.(KPTI)5,675,8765,102,193-573,683$7.61M$4.41M0.40%-$3.19M
Relmada Therapeutics, Inc.(RLMD)732,400732,4000$2.20M$3.03M0.27%+$834.9K
Mirum Pharmaceuticals, Inc.(MIRM)64,70064,7000$2.04M$1.91M0.17%-$134.6K
Vanda Pharmaceuticals Inc.(VNDA)278,985278,9850$1.21M$1.18M0.11%-$27.9K
Yarrow Bioscience Inc(YARW)0445,434+445,434$0$1.04M0.09%+$1.04M
Travere Therapeutics, Inc.(TVTX)166,069110,719-55,350$1.48M$995.4K0.09%-$489.3K
Taysha Gene Therapies, Inc.(TSHA)0529,861+529,861$0$937.9K0.08%+$937.9K
Sight Sciences, Inc.(SGHT)0173,790+173,790$0$896.8K0.08%+$896.8K
Aldeyra Therapeutics, Inc.(ALDX)160,800225,465+64,665$1.07M$791.4K0.07%-$282.8K
UroGen Pharma Ltd.(URGN)24,50024,5000$343.2K$367.5K0.03%+$24.3K
KEZAR LIFE SCIENCES INCCOM656,2000-656,200$780.9K$0—-$780.9K
TACTILE SYSTEMS TECHNOLOGY ICOM(TCMD)27,1000-27,100$380.8K$0—-$380.8K
Page 1 of 1